Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00762801

Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of North Texas Health Science Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

RLIP76 (Ral binding protein1) is a 76 kDa splice variant protein encoded by the human gene (RALBP1, 18p11.22). It is a multifunctional modular protein found ubiquitously from Drosophila to humans, in cells ranging from red blood cells to endothelial cells of the brain. Its expression more predominant in breast, heart, liver and less so in colon and brain parenchyma.

Detailed description

RLIP76 is shown to be over expressed in a variety of cancer cells. However, no study has yet been done on its expression on normal cells. The studies proposed in this project will study the expression of RLIP76 in blood cells of healthy human subjects in the population of North Texas region.

Conditions

Timeline

Start date
2008-09-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2008-09-30
Last updated
2016-10-26

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00762801. Inclusion in this directory is not an endorsement.